Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05534607 · ClinicalTrials.gov registry record · NA

Natives Engaged in Alzheimers Research - 'Ike Kupuna

A NA study of Mild Cognitive Impairment and Subjective Cognitive Impairment, sponsored by University of Hawaii.

Recruiting
Registry status
NA
Development phase
192
Enrollment target
3
Study locations

NCT05534607 is a NA study of Mild Cognitive Impairment and Subjective Cognitive Impairment that is actively recruiting participants, run by University of Hawaii. The registered enrollment target is 192 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05534607, a NA study of Mild Cognitive Impairment and Subjective Cognitive Impairment, is actively recruiting participants, sponsored by University of Hawaii.

RECRUITING
Registry status
NA
Development phase
192 participants
Enrollment target
3
Study locations

Study Summary

This study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function over 12 months.

Interventions

  • BEHAVIORAL Ola Mau i ka Hula

Study Locations (3)

Hawaii

  • Kula No Na Po'e - Honolulu
  • Kokua Kalihi Valley - Honolulu
  • Hui No Ke Ola Pono - Wailuku

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2022-09-15
Est. Completion 2027-04-30
Phase NA

Sponsor

University of Hawaii

77 total trials

What the Registry Record Tells You About NCT05534607

The ClinicalTrials.gov registry entry for NCT05534607 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (85% lower). The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Ola Mau i ka Hula is the first listed.

NCT05534607 reports 3 study locations spanning 1 distinct geographic area - top geographies include Hawaii.

Frequently Asked Questions

What is clinical trial NCT05534607 about?

NCT05534607 is a clinical study titled "Natives Engaged in Alzheimers Research - 'Ike Kupuna". This study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function over 12 months.

What is the current status of trial NCT05534607?

This trial is currently recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2022-09-15. Estimated completion is 2027-04-30.

What conditions does trial NCT05534607 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Subjective Cognitive Impairment.

What interventions are being tested in trial NCT05534607?

The interventions under investigation include: Ola Mau i ka Hula (BEHAVIORAL).

Who is sponsoring clinical trial NCT05534607?

This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05534607 being conducted?

This trial has 3 study locations across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.